Medicine at Risk: The National Se...
Medicine at Risk: The National Security Threat in America’s Drug Supply Chain

Deep Dive Dispatch di With John Matthews and Sarah Collins

Note sull'episodio

Can America’s reliance on foreign pharmaceutical manufacturing jeopardize its health and security?

On this episode of 'Deep Dive Dispatch,' we uncover the hidden vulnerabilities in the U.S. drug supply chain, from supply disruptions to geopolitical risks.

Discover how over-dependence on China and India could spell trouble and explore the government’s efforts—like Executive Order 13944—to secure essential medicines.

With expert insights on domestic manufacturing, transparency, and the Strategic National Stockpile, we’ll reveal what’s at stake and how to build a safer, more resilient system.

Tune in to learn why securing our medicine isn’t just a health issue—it’s a matter of survival.

Parole chiave
Agenda 47TrumpUS Pharmaceutical Supply ChainMedicine SecurityNational Security RisksDrug Supply VulnerabilityPharmaceutical ManufacturingForeign DependencyActive Pharmaceutical Ingredients (API)Supply Chain DisruptionsStrategic National StockpileExecutive Order 13944Domestic Drug ProductionPublic Health PolicyGeopolitical Impact on MedicinePharmaceutical ImportsGovernment InitiativesDrug TransparencyResilient Healthcare SystemsChina and India Pharma DependencyHealthcare Security